Pfizer has created a new antiviral drug for coronavirus infection Paxlovid (PF-332). Biologists have already proven its effectiveness. The results of the study are published in the journal Nature Communications.. The company claims that this development will help prevent the spread of the virus that causes COVID-19 between humans and animals.. It is also able to protect against infection with Delta and Beta strains.. This was confirmed by in vivo studies based on Syrian hamsters..

It is noted that the mechanism of action of the drug is based on the destruction of the Mpro protein.. It is he who is the main enzyme of the shell of the coronavirus. And when it was doubled, the spread of SARS-CoV-2 in the body completely stopped and recovery was significantly accelerated.. Recall that earlier scientists found that hemp compounds can block the penetration of the SARS-CoV-2 virus into human cells.. US scientists discover monoclonal antibodies that neutralize Omicron. Subscribe to our channel https://t. me/korrespondentnet Author: 1.